rs72552053

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_021098.3(CACNA1H):​c.5825C>T​(p.Ala1942Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000485 in 1,565,426 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1942S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000038 ( 2 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.590

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10128817).
BP6
Variant 16-1218589-C-T is Benign according to our data. Variant chr16-1218589-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 529550.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000145 (22/152188) while in subpopulation AFR AF = 0.000482 (20/41518). AF 95% confidence interval is 0.000319. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 22 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5825C>T p.Ala1942Val missense_variant Exon 33 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5825C>T p.Ala1942Val missense_variant Exon 33 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5840C>T p.Ala1947Val missense_variant Exon 32 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5843C>T p.Ala1948Val missense_variant Exon 32 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5807C>T p.Ala1936Val missense_variant Exon 32 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5840C>T p.Ala1947Val missense_variant Exon 33 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5825C>T p.Ala1942Val missense_variant Exon 33 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5786C>T p.Ala1929Val missense_variant Exon 33 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5807C>T p.Ala1936Val missense_variant Exon 32 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5768C>T p.Ala1923Val missense_variant Exon 32 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5825C>T p.Ala1942Val missense_variant Exon 33 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5807C>T p.Ala1936Val missense_variant Exon 32 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5825C>T p.Ala1942Val missense_variant Exon 33 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5825C>T p.Ala1942Val missense_variant Exon 33 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5825C>T p.Ala1942Val missense_variant Exon 33 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5825C>T non_coding_transcript_exon_variant Exon 33 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1777C>T non_coding_transcript_exon_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*906C>T non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3676C>T non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5269C>T non_coding_transcript_exon_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*799C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*684C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1437C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*492C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*492C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5807C>T non_coding_transcript_exon_variant Exon 32 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5825C>T non_coding_transcript_exon_variant Exon 33 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5825C>T non_coding_transcript_exon_variant Exon 33 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*941C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1777C>T 3_prime_UTR_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*906C>T 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3676C>T 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5269C>T 3_prime_UTR_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*799C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*684C>T 3_prime_UTR_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1437C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*492C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*492C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*941C>T 3_prime_UTR_variant Exon 33 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152070
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000686
AC:
12
AN:
174838
AF XY:
0.0000745
show subpopulations
Gnomad AFR exome
AF:
0.000207
Gnomad AMR exome
AF:
0.000113
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000156
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000139
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000382
AC:
54
AN:
1413238
Hom.:
2
Cov.:
38
AF XY:
0.0000372
AC XY:
26
AN XY:
698444
show subpopulations
African (AFR)
AF:
0.000462
AC:
15
AN:
32446
American (AMR)
AF:
0.000106
AC:
4
AN:
37686
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25324
East Asian (EAS)
AF:
0.0000538
AC:
2
AN:
37184
South Asian (SAS)
AF:
0.000174
AC:
14
AN:
80364
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48724
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5706
European-Non Finnish (NFE)
AF:
0.0000129
AC:
14
AN:
1087240
Other (OTH)
AF:
0.0000854
AC:
5
AN:
58564
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000145
AC:
22
AN:
152188
Hom.:
0
Cov.:
30
AF XY:
0.000161
AC XY:
12
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.000482
AC:
20
AN:
41518
American (AMR)
AF:
0.00
AC:
0
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68004
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000107
Hom.:
0
Bravo
AF:
0.000159
ESP6500AA
AF:
0.000250
AC:
1
ESP6500EA
AF:
0.000121
AC:
1
ExAC
AF:
0.0000427
AC:
5
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jul 17, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.5825C>T (p.A1942V) alteration is located in exon 33 (coding exon 32) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 5825, causing the alanine (A) at amino acid position 1942 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Apr 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
3.3
DANN
Benign
0.91
DEOGEN2
Benign
0.19
T;.;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.63
T;T;T;.
M_CAP
Pathogenic
0.50
D
MetaRNN
Benign
0.10
T;T;T;T
MetaSVM
Uncertain
0.011
D
MutationAssessor
Benign
1.8
L;.;.;.
PhyloP100
0.59
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.9
N;.;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.13
T;.;T;T
Sift4G
Benign
0.32
T;.;T;T
Polyphen
0.0010
B;.;B;B
Vest4
0.13
MVP
0.84
ClinPred
0.011
T
GERP RS
-0.20
Varity_R
0.048
gMVP
0.40
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72552053; hg19: chr16-1268589; API